The Cytoplasmic Tyrosine Kinase Pyk2 as a Novel Effector of Fibroblast Growth Factor Receptor 3 Activation
Open Access
- 1 July 2004
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 279 (27) , 28450-28457
- https://doi.org/10.1074/jbc.m403335200
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Interaction of Fibroblast Growth Factor Receptor 3 and the Adapter Protein SH2-BPublished by Elsevier ,2002
- SHP2 Mediates the Protective Effect of Interleukin-6 against Dexamethasone-induced Apoptosis in Multiple Myeloma CellsJournal of Biological Chemistry, 2000
- Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4Oncogene, 2000
- Regulation of Calcium-sensitive Tyrosine Kinase Pyk2 by Angiotensin II in Endothelial CellsPublished by Elsevier ,2000
- FGFs, heparan sulfate and FGFRs: complex interactions essential for developmentBioEssays, 2000
- RAFTK/PYK2-dependent and -independent apoptosis in multiple myeloma cellsOncogene, 1999
- RAFTK, a Novel Member of the Focal Adhesion Kinase Family, Is Phosphorylated and Associates with Signaling Molecules upon Activation of Mature T LymphocytesThe Journal of Experimental Medicine, 1997
- Activation of a Novel Calcium-dependent Protein-tyrosine KinasePublished by Elsevier ,1996
- Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3Nature Genetics, 1995
- Signal transduction by receptors with tyrosine kinase activityPublished by Elsevier ,1990